Treatment approaches for severe Stenotrophomonas maltophilia infections
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment approaches for severe Stenotrophomonas maltophilia infections
Authors
Keywords
-
Journal
CURRENT OPINION IN INFECTIOUS DISEASES
Volume 36, Issue 6, Pages 572-584
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2023-10-17
DOI
10.1097/qco.0000000000000975
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vitro susceptibilities of Stenotrophomonas maltophilia isolates to antimicrobial agents commonly used for related Infections: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2004-2020
- (2023) Yu-Lin Lee et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Multicenter Evaluation of an MIC-Based Aztreonam and Ceftazidime-Avibactam Broth Disk Elution Test
- (2023) Harley Harris et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Appropriate antibiotic therapy is a predictor of outcome in patients with Stenotrophomonas maltophilia blood stream infection in the intensive care unit
- (2023) Jiun-Ji Lai et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Steno‐sphere: Navigating the enigmatic world of emerging multidrug‐resistantStenotrophomonas maltophilia
- (2023) Ashlan J. Kunz Coyne et al. PHARMACOTHERAPY
- Stenotrophomonas maltophilia pneumonia in critical COVID-19 patients
- (2023) Marc Raad et al. Scientific Reports
- Assessment of the relative benefits of monotherapy and combination therapy approaches to the treatment of hospital-acquired Stenotrophomonas maltophilia pneumonia: a multicenter, observational, real-world study
- (2023) Liang Chen et al. Annals of Intensive Care
- Global prevalence and distribution of antibiotic resistance among clinical isolates of Stenotrophomonas maltophilia: A systematic review and meta-analysis
- (2023) Masoud Dadashi et al. Journal of Global Antimicrobial Resistance
- Successful Treatment of Persistent Stenotrophomonas maltophilia Bacteremia With Cefiderocol in an Infant
- (2023) Alice J Hsu et al. Open Forum Infectious Diseases
- Global prevalence and antibiotic resistance in clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis
- (2023) Maryam Banar et al. Frontiers in Medicine
- Stenotrophomonas maltophilia Infections: A Systematic Review and Meta-Analysis of Comparative Efficacy of Available Treatments, with Critical Assessment of Novel Therapeutic Options
- (2023) Alberto Enrico Maraolo et al. Antibiotics-Basel
- Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections
- (2023) Pranita D Tamma et al. CLINICAL INFECTIOUS DISEASES
- Synergistic combination of aztreonam and ceftazidime/avibactam against resistant Stenotrophomonas maltophilia on pancreatitis
- (2023) Natália De Almeida Torres et al. Journal of Infection in Developing Countries
- First case of persistent Stenotrophomonas maltophilia bacteraemia due to septic thrombosis successfully treated with a cefiderocol-containing regimen
- (2023) Filippo Medioli et al. Journal of Global Antimicrobial Resistance
- The Prognosis of Patients Tested Positive for Stenotrophomonas maltophilia from Different Sources
- (2023) Ru Ma et al. Infection and Drug Resistance
- In vitro Time Kill of Trimethoprim/Sulfamethoxazole against Stenotrophomonas maltophilia versus Escherichia coli using Cation Adjusted Muller Hinton Broth and ISO-Sensitest Broth
- (2022) Maxwell J. Lasko et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Minocycline pharmacodynamics against Stenotrophomonas maltophilia in the neutropenic murine infection model: implications for susceptibility breakpoints
- (2022) Andrew J. Fratoni et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Trimethoprim-Sulfamethoxazole Versus Levofloxacin for Stenotrophomonas maltophilia Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 US Hospitals
- (2022) Sadia H Sarzynski et al. Open Forum Infectious Diseases
- Overcoming Stenotrophomonas maltophilia Resistance for a More Rational Therapeutic Approach
- (2022) Ravina Kullar et al. Open Forum Infectious Diseases
- In Vitro Comparison of Aztreonam/Amoxicillin-Clavulanate Versus Aztreonam/Ceftazidime-Avibactam on Ceftazidime-Avibactam Resistant Stenotrophomonas maltophilia
- (2022) Lise Crémet et al. Microbial Drug Resistance
- Infections With Stenotrophomonas maltophilia in Children Undergoing Anticancer Therapy or Hematopoietic Cell Transplantation: A Multicenter Nationwide Study
- (2022) Monika Richert-Przygonska et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Stenotrophomonas maltophilia Infection Associated with COVID-19: A Case Series and Literature Review
- (2022) Kazuhiro Ishikawa et al. American Journal of Case Reports
- Successful treatment of MDR Stenotrophomonas maltophilia-associated pneumonia with cefiderocol-based regimen in a patient with hematological malignancy
- (2022) Emanuela Zappulo et al. ANNALS OF HEMATOLOGY
- Prognosis of hospital‐acquired pneumonia/ventilator‐associated pneumonia with Stenotrophomonas maltophilia versus Klebsiella pneumoniae in intensive care unit: A retrospective cohort study
- (2022) Shuping Chen et al. Clinical Respiratory Journal
- Trimethoprim/sulfamethoxazole pharmacodynamics against Stenotrophomonas maltophilia in the in vitro chemostat model
- (2022) Maxwell J Lasko et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Trends in Stenotrophomonas maltophilia antibiotic resistance rates in the United States Veterans Affairs Health System
- (2022) Haley J. Appaneal et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Pharmacokinetics of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase 1, Open-Label Study of Healthy Adults
- (2022) Thomas P. Lodise et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment, clinical outcomes, and predictors of mortality among a national cohort of hospitalized patients with Stenotrophomonas maltophilia infection
- (2022) H.J. Appaneal et al. PUBLIC HEALTH
- Molecular Epidemiology of Stenotrophomonas maltophilia Strains Isolated from Bacteremia in Hospitalized Children
- (2022) Hadis Divakan et al. Oman Medical Journal
- Stenotrophomonas maltophilia bacteremia in children: risk factors and mortality rate
- (2021) Mohammed Alsuhaibani et al. Antimicrobial Resistance and Infection Control
- In Vitro Activity and In Vivo Efficacy of Cefiderocol Against Stenotrophomonas maltophilia
- (2021) Rio Nakamura et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- StenoSCORE: Predicting Stenotrophomonas maltophilia Bloodstream Infections in the Hematologic Malignancy Population
- (2021) Sara M. Karaba et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Advances in the Microbiology of Stenotrophomonas maltophilia
- (2021) Joanna S. Brooke CLINICAL MICROBIOLOGY REVIEWS
- Clinical outcomes of Stenotrophomonas maltophilia infection treated with trimethoprim/sulfamethoxazole, minocycline, or fluoroquinolone monotherapy
- (2021) Shauna Jacobson Junco et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Levofloxacin pharmacodynamics against Stenotrophomonas maltophilia in a neutropenic murine thigh infection model: implications for susceptibility breakpoint revision
- (2021) Andrew J Fratoni et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Evaluation of the Vitek 2, Phoenix, and MicroScan for Antimicrobial Susceptibility Testing of Stenotrophomonas maltophilia
- (2021) Ayesha Khan et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Multicenter surveillance of antimicrobial susceptibilities and resistance mechanisms among Enterobacterales species and non-fermenting Gram-negative bacteria from different infection sources in Taiwan from 2016 to 2018
- (2021) Shio-Shin Jean et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Stenotrophomonas maltophilia bacteraemia: 61 cases in a tertiary hospital in Denmark
- (2021) Magnus G. Ahlström et al. Infectious Diseases
- In Vitro Susceptibility of Gram-Negative Pathogens to Cefiderocol in Five Consecutive Annual Multinational SIDERO-WT Surveillance Studies, 2014 to 2019
- (2021) James A. Karlowsky et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Infectious Diseases Society of America Guidance on the Treatment of AmpC β-lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections
- (2021) Pranita D Tamma et al. CLINICAL INFECTIOUS DISEASES
- Antimicrobial Treatment Strategies for Stenotrophomonas maltophilia: A Focus on Novel Therapies
- (2021) Jean Gibb et al. Antibiotics-Basel
- The Clinical and Laboratory Standards Institute Subcommittee on Antimicrobial Susceptibility Testing: Background, Organization, Functions, and Processes
- (2020) Melvin P. Weinstein et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Multicenter surveillance of the epidemiology of gram-negative bacteremia in Japan
- (2020) Kosuke Kosai et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Determining the optimal dosing of a novel combination regimen of ceftazidime/avibactam with aztreonam against NDM-1-producing Enterobacteriaceae using a hollow-fibre infection model
- (2020) Thomas P Lodise et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The phylogenetic landscape and nosocomial spread of the multidrug-resistant opportunist Stenotrophomonas maltophilia
- (2020) Matthias I. Gröschel et al. Nature Communications
- Stenotrophomonas maltophilia Infections: Clinical Characteristics and Factors Associated with Mortality of Hospitalized Patients
- (2020) Worachart Insuwanno et al. Infection and Drug Resistance
- The Burden of Bloodstream Infections due to Stenotrophomonas Maltophilia in the United States: A Large, Retrospective Database Study
- (2020) Bin Cai et al. Open Forum Infectious Diseases
- Molecular epidemiology and risk factors of Stenotrophomonas maltophilia infections in a Chinese teaching hospital
- (2020) Zhongliang Duan et al. BMC MICROBIOLOGY
- Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
- (2020) Matteo Bassetti et al. LANCET INFECTIOUS DISEASES
- Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial
- (2020) Richard G Wunderink et al. LANCET INFECTIOUS DISEASES
- Optimization of Aztreonam in Combination with Ceftazidime/Avibactam in a Cystic Fibrosis Patient with Chronic Stenotrophomonas maltophilia Pneumonia Using Therapeutic Drug Monitoring
- (2020) Mallory C. Cowart et al. THERAPEUTIC DRUG MONITORING
- Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016)
- (2019) Ana C Gales et al. Open Forum Infectious Diseases
- In vivo pharmacodynamic study of cefiderocol, a novel parenteral siderophore cephalosporin, in murine thigh and lung infection models
- (2019) Rio Nakamura et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Minocycline against U.S. Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus species complex, Stenotrophomonas maltophilia, and Burkholderia cepacia complex: Results from the SENTRY Antimicrobial Surveillance Program (2014-2018)
- (2019) Robert K. Flamm et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical and Microbiologic Outcomes in Patients with Monomicrobial Stenotrophomonas maltophilia infections
- (2019) Cara Nys et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis–data from the European cystic fibrosis society patient registry
- (2019) Elpis Hatziagorou et al. Journal of Cystic Fibrosis
- Imaging findings of Stenotrophomonas maltophilia pneumonia: emphasis on CT findings between immunocompromised and immunocompetent patients
- (2019) Yeo Ryang Kang et al. ACTA RADIOLOGICA
- Comparative In Vivo Antibacterial Activity of Human-Simulated Exposures of Cefiderocol and Ceftazidime against Stenotrophomonas maltophilia in the Murine Thigh Model
- (2019) Iris H. Chen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Cefiderocol Against a Broad Range of Clinically Important Gram-negative Bacteria
- (2019) Yoshinori Yamano CLINICAL INFECTIOUS DISEASES
- The clinical impact of Stenotrophomonas maltophilia bacteremia on the 30-day mortality rate in patients with hematologic disorders: a single-institution experience
- (2019) Haiyan Bao et al. INFECTION
- Activity of potential alternative treatment agents for Stenotrophomonas maltophilia non-susceptible to levofloxacin and/or trimethoprim/sulfamethoxazole
- (2019) M Biagi et al. JOURNAL OF CLINICAL MICROBIOLOGY
- TonB‐dependent uptake of β‐lactam antibiotics in the opportunistic human pathogen Stenotrophomonas maltophilia
- (2019) Karina Calvopiña et al. MOLECULAR MICROBIOLOGY
- Microbial Interactions in the Cystic Fibrosis Airway
- (2018) Ann M Granchelli et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Detection of blaNDM-1 in Stenotrophomonas maltophilia isolated from Brazilian soil
- (2018) João Pedro Rueda Furlan et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Frequency and antimicrobial susceptibility of Gram-negative bacteria isolated from patients with pneumonia hospitalized in ICUs of US medical centres (2015–17)
- (2018) Helio S Sader et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Discrepancies between Various Methods in Susceptibility Testing and Epidemiological Analysis of Stenotrophomonas maltophilia Clinical Isolates
- (2018) Aikaterini Masgala et al. Central European Journal of Public Health
- In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan
- (2018) Shun-Chung Hsueh et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- I.V. minocycline revisited for infections caused by multidrug-resistant organisms
- (2016) Benjamin Colton et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis
- (2016) Elizabeth L. Salsgiver et al. CHEST
- Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia
- (2016) Yong Duk Jeon et al. MEDICINE
- Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments
- (2016) Chuanqi Wei et al. PLoS One
- Comparative Activity of Ciprofloxacin, Levofloxacin and Moxifloxacin against Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia Assessed by Minimum Inhibitory Concentrations and Time-Kill Studies
- (2016) Antoine Grillon et al. PLoS One
- Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations
- (2015) Sung-Yeon Cho et al. BMC INFECTIOUS DISEASES
- High-level quinolone resistance is associated with the overexpression of smeVWX in Stenotrophomonas maltophilia clinical isolates
- (2015) G. García-León et al. CLINICAL MICROBIOLOGY AND INFECTION
- Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options
- (2015) Ya-Ting Chang et al. Frontiers in Microbiology
- Phenotypic Heterogeneity Affects Stenotrophomonas maltophilia K279a Colony Morphotypes and β-Lactamase Expression
- (2015) Ebrahim M. Abda et al. Frontiers in Microbiology
- A Monte Carlo pharmacokinetic/pharmacodynamic simulation to evaluate the efficacy of minocycline, tigecycline, moxifloxacin, and levofloxacin in the treatment of hospital-acquired pneumonia caused byStenotrophomonas maltophilia
- (2015) Chuanqi Wei et al. Infectious Diseases
- Characterization of Environmental CTX-M-15-Producing Stenotrophomonas maltophilia
- (2014) Ana Maravić et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibiotic-Resistant Gram-Negative Bacterial Infections in Patients With Cancer
- (2014) Federico Perez et al. CLINICAL INFECTIOUS DISEASES
- Interplay between intrinsic and acquired resistance to quinolones inStenotrophomonas maltophilia
- (2014) Guillermo García-León et al. ENVIRONMENTAL MICROBIOLOGY
- Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: Results from the SENTRY Antimicrobial Surveillance Program, 2009–2012
- (2014) Helio S. Sader et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Monotherapy with Fluoroquinolone or Trimethoprim-Sulfamethoxazole for Treatment of Stenotrophomonas maltophilia Infections
- (2013) Yu Lin Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Can Levofloxacin Be a Useful Alternative to Trimethoprim-Sulfamethoxazole for Treating Stenotrophomonas maltophilia Bacteremia?
- (2013) Sun Young Cho et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Adverse Effects of Antimicrobials via Predictable or Idiosyncratic Inhibition of Host Mitochondrial Components
- (2012) Alison E. Barnhill et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
- (2012) J. S. Brooke CLINICAL MICROBIOLOGY REVIEWS
- Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008–2010)
- (2012) Ana C. Gales et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009–2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)
- (2012) Po-Liang Lu et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Proteomic Analysis of Clinical Isolate of Stenotrophomonas maltophilia with blaNDM-1,blaL1 and blaL2 β-Lactamase Genes under Imipenem Treatment
- (2012) Wei Liu et al. JOURNAL OF PROTEOME RESEARCH
- Expression of Sme Efflux Pumps and Multilocus Sequence Typing in Clinical Isolates ofStenotrophomonas maltophilia
- (2012) Hye Hyun Cho et al. Annals of Laboratory Medicine
- The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach
- (2011) J.W. Mouton et al. CLINICAL MICROBIOLOGY AND INFECTION
- Aminoglycoside modifying enzymes
- (2010) Maria S. Ramirez et al. DRUG RESISTANCE UPDATES
- Risk factors for mortality among patients with Stenotrophomonas maltophilia bacteremia in Tokyo, Japan, 1996–2009
- (2010) H. Araoka et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Comparison of different antimicrobial susceptibility testing methods for Stenotrophomonas maltophilia and results of synergy testing
- (2010) Dolunay Gülmez et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008
- (2010) Julia Emerson et al. PEDIATRIC PULMONOLOGY
- SmQnr Contributes to Intrinsic Resistance to Quinolones in Stenotrophomonas maltophilia
- (2009) M. B. Sanchez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Community-acquired Stenotrophomonas maltophilia infections: a systematic review
- (2009) M. E. Falagas et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Attributable mortality ofStenotrophomonas maltophiliainfections: a systematic review of the literature
- (2009) Matthew E Falagas et al. Future Microbiology
- Multidrug resistance in clinical isolates of Stenotrophomonas maltophilia: roles of integrons, efflux pumps, phosphoglucomutase (SpgM), and melanin and biofilm formation
- (2009) S.-J. Liaw et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Stenotrophomonas maltophilia: an emerging opportunist human pathogen
- (2009) W John Looney et al. LANCET INFECTIOUS DISEASES
- Induction of L1 and L2 -Lactamase Production in Stenotrophomonas maltophilia Is Dependent on an AmpR-Type Regulator
- (2008) A. Okazaki et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review
- (2008) J.I. Garcia Paez et al. JOURNAL OF HOSPITAL INFECTION
- The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants
- (2008) Lisa C Crossman et al. GENOME BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started